ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,862 | -2.9% | 5,950 | +52.2% | 0.00% | – |
| Q2 2023 | $19,433 | +16.2% | 3,910 | +15.5% | 0.00% | – |
| Q1 2023 | $16,722 | +368.0% | 3,385 | +496.0% | 0.00% | – |
| Q4 2022 | $3,573 | -87.2% | 568 | -77.9% | 0.00% | -100.0% |
| Q3 2022 | $28,000 | -3.4% | 2,569 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | +262.5% | 2,569 | +198.7% | 0.00% | – |
| Q1 2022 | $8,000 | – | 860 | +2865.5% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 29 | -71.0% | 0.00% | – |
| Q3 2021 | $3,000 | +200.0% | 100 | +233.3% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 30 | +11.1% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 27 | -35.7% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 42 | -68.2% | 0.00% | – |
| Q1 2020 | $3,000 | – | 132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |